High Altitude Training: Benefits for Athletic Performance

Live High, Train Low (LHTL) is the evidence-based paradigm: sleep at altitude (2,000–3,000 m), train at lower elevation to maintain intensity.

Physiological Adaptations

• Erythropoiesis: Hypoxia → renal EPO ↑ → reticulocytosis → increased hemoglobin mass & O₂ carrying capacity (peaks 3–4 weeks).
• VO₂max Enhancement: Greater O₂ delivery → higher maximal aerobic power.
• Metabolic Efficiency: Increased mitochondrial density, capillary density, buffering capacity.
• Ventilatory Acclimatization: Enhanced hypoxic ventilatory response (HVR).
• Potential Muscle Benefits: Fiber type shifts, growth hormone/IGF-1 modulation (less consistent).

Practical Protocols

• Natural LHTL: Sleep ≥2,500 m, train ≤1,500 m. 3–4 weeks minimum.
• Artificial: Normobaric hypoxia tents/rooms (FiO₂ 14–15.5%), intermittent hypoxic exposure (IHE), intermittent hypoxic training (IHT).

Risks & Considerations

• Acute mountain sickness (AMS), HAPE, HACE — gradual ascent, hydration, acetazolamide prophylaxis.
• Sleep disruption, reduced training intensity at altitude, immune suppression, iron deficiency (monitor ferritin, supplement).
• Individual responders vs. non-responders (genetic, baseline Hb, iron status).
• Cost, logistics, ethical concerns (simulated altitude).

Performance Outcomes

Meta-analyses: ~1–3% improvement in endurance performance (running, cycling, swimming) for responders. Most beneficial for events >2 min (5k–marathon, cycling, XC skiing).

Supervised, periodized integration into annual plan maximizes benefit/minimizes risk.